CORRESP Filing
IceCure Medical Ltd.
Date: April 8, 2026 · CIK: 0001584371 · Accession: 0001213900-26-041535
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294827
Letter
VIA EDGAR Securities and Exchange Commission Division of Corporation Finance United States Securities and Exchange Commission Washington, D.C. 20549 Re: IceCure Medical Ltd. (CIK 0001584371) Registration Statement on Form F-1 (File No. 333-294827) (the “Registration Statement”) Request for Acceleration of Effective Date
Dear Sir or Madam:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Securities Act”), IceCure Medical Ltd. (the “Registrant”) hereby requests that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective on April 10, 2026 at 4:15 p.m., Eastern Time, or as soon as practicable thereafter.
The Registrant respectfully requests that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212) 660-3092 and that such effectiveness also be confirmed in writing.
Very truly yours,
IceCure Medical Ltd.
Show Raw Text
CORRESP
1
filename1.htm
IceCure Medical Ltd.
7 Ha’Eshel St., PO Box 3163
Caesarea, 3079504 Israel
April 8, 2026
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
United States Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re:
IceCure Medical Ltd. (CIK 0001584371)
Registration Statement on Form F-1 (File No. 333-294827) (the “Registration Statement”)
Request for Acceleration of Effective Date
Dear Sir or Madam:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended (the “Securities Act”), IceCure Medical Ltd. (the “Registrant”) hereby
requests that the effective date of the above-referenced Registration Statement be accelerated so that it will be declared effective on
April 10, 2026 at 4:15 p.m., Eastern Time, or as soon as practicable thereafter.
The Registrant respectfully requests
that it be notified of such effectiveness by a telephone call to Eric Victorson, Esq. of Sullivan & Worcester LLP at (212) 660-3092
and that such effectiveness also be confirmed in writing.
Very truly yours,
IceCure Medical Ltd.
By:
/s/
Eyal Shamir
Name:
Eyal Shamir
Title:
Chief Executive Officer